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Purposes: To compare pulmonary radioaerosol deposition during jet nebulization
associated to noninvasive ventilation versus spontaneous breathing nebulization; to
measure the rate of lung depuration and the correlation between lung deposition,
inspiratory flow and tidal volume (Vt) using scintigraphy.
Subjects: Thirteen healthy volunteers (with normal spirometry), mean age
(23.371.49) years, body mass index 21.272.3 kg/m2.
Methods: Nebulization was performed in spontaneous breathing and associated with
bi-level noninvasive ventilation (inspiratory pressure ¼ 12 cm H2O, expiratory
pressure ¼ 5 cm H2O). The radioaerosol used in the nebulization was technetium
(Tc99m) with diethylene triamine penta acetic acid, generated over a period of 9min
in a jet nebulizer. Analysis was performed through scintigraphy. Statistical analysis
was performed by analysis of variance (for repeated measures), Bonferroni method,
Student’s t-test and Person’s correlation.
Results: There was a decrease in radioaerosol lung deposition with nebulization
associated to noninvasive ventilation (mean counts in spontaneous breathing
200,510+11,012 and mean counts in noninvasive ventilation 106,093+2811
(Po0:001). During spontaneous breathing nebulization there was a significant
correlation between Vt and radioaerosol deposition (r ¼ 0:565, Po0:05), alsoElsevier Ltd. All rights reserved.
99738965; fax: +55 8121268490.
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Po0:05). However, there was no correlation between Vt and pulmonary deposition of
radioaerosol in bi-level noninvasive ventilation nebulization (r ¼ 0:082).
Conclusion: During nebulization with noninvasive ventilation in healthy volunteers,
there was an increase in Vt associated to a higher inspiratory flow rate, without
resulting in a significant increase in pulmonary radioaerosol deposition.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Noninvasive ventilation has been used to treat
acute and chronic respiratory failure due to several
diseases.1–3 Despite the amount of therapies used
to treat respiratory diseases, the inhaling therapy is
usually focused in our clinical practice using
metered-dose inhaler (MDI),4,5 dry powder inhaler
(DPI)6,7 or nebulizers.8–10
Nebulization associated with noninvasive venti-
lation (NV) is used in emergency services and
intensive care units, not only as a form of reverting
bronchial obstruction and also to reduce work of
breathing. The efficiency of nebulized drug during
nebulization by NV depends on the effectiveness of
the drug deposition in the lungs.11,12
In practice, it is common to associate inhalatory
route with NV in asthmatic and COPD patients
during acute exacerbation. To date, there are few
studies about inhalatory therapeutics associated
with NV. This association was first studied by
Dolovich et al.13 In this study, scintigraphy was
used to analyze peripheral deposition of aerosol
during intermittent positive pressure breathing
comparing to spontaneous breathing in nine stable
COPD patients and showed that there was no
increase in peripheral deposition of aerosol during
intermittent positive pressure breathing. In an-
other study, Pollack et al.12 analyzed the treatment
of acute bronchial spasm with b-adrenergic agonist
delivered as an aerosol, made by nasal masks in bi-
level positive airway pressure (BiPAP), with in-
spiratory positive airway pressure (IPAP) of 10 cm
H2O and expiratory positive airway pressure (EPAP)
of 5 cm H2O. One hundred patients in an emergency
center showing clinical wheezing in chest were
studied and there was a significant increase of PEF
in the group that used BiPAP2. Unfortunately only
the PEF was analyzed.
Since nebulization is one of the most efficient
way of administering drugs to asthmatic and COPD
patients, children and adults in emergency units, it
can be interesting to analyze the pulmonary
regional deposition of radioaerosol when adminis-
tered by nebulization associated with NV.
The aims of the present study were: (1) to
analyze the pulmonary radioaerosol depositionthrough scintigraphy, after using a jet nebulizer in
spontaneous breathing (SB) and after nebulization
associated to bi-level NV; (2) to analyze the
rate of depuration in the lungs and correlate
pulmonary deposition with inspiratory flow and
tidal volume (Vt).Methods
Subjects
Thirteen healthy volunteers (nine females and four
males) were studied. Their mean age was
23.471.49 (SD) years, body mass index (BMI) was
21.272.3 kg/m2. Exclusion criteria were: history of
smoking or respiratory problems, pregnancy,
breathing rate 420 bpm, heart rate o50 or
4100 bpm, oxygen saturation (SpO2) p90%, max-
imal inspiratory pressurep50 cm H2O, Vtp6ml/kg,
or forced vital capacity (FVC) o81% and forced
expiratory volume on the 1 s (FEV1) o82% of
predicted values. The protocol was approved by
the Ethical Committee from all and the subjects
gave written informed consent.Measurements and procedure
Volunteers were enquired about their age, history
of smoking and any previous pulmonary illness.
Anthropometric data {weight, height and body
mass index (BMI)}, and cardiopulmonary assessment
were then carried out: breathing rate (BR), heart
rate (HR) and transcutaneous oxygen saturation
(SpO2) were measured by pulse oximetry (ACTIVE;
Ecaflex; Sa˜o Paulo, Brazil). PEF (ASTECH; Center
Laboratories; New York, USA) was used to assess
bronchial obstruction. Maximal inspiratory pressure
(MIP) was obtained using a manometer (MV-150,
Marshal-Town Instrument Industry, USA), according
to the method of Black and Hyatt.14 Ventilometry
was performed with a respirometer (Wright Respi-
rometer Mark 8; Ferraris Medical Ltd; England). FVC
and FEV1 were measured using a spirometer
(Satellite, Subminiature ad Jones Spirometer,
Windsor, England), considering Knudson’s values.15
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Figure 1 Delimitation of the regions of interest (ROIs):
(a) upper, middle and lower pulmonary regions; (b)
central, intermediate and peripheralpulmonary regions.
Nebulization and noninvasive ventilation 723After initial evaluation and following the exclu-
sion criteria, the volunteers attended the Medicine
Nuclear Service, where they underwent nebuliza-
tion in two phases, one in SB and another in
association with bi-level NV, with a minimum
interval of 7 days between each phase. The choice
of the first phase was done by a random selection.
In both phases, the radioaerosol used was
Tc99m—DTPA (25mCi), generated in jet nebulizer
(ST3; NS; Sa˜o Paulo, Brazil) placed in a lead box
(ULTRAVENT; Mallinckrodt Medical; St. Louis, USA),
and then diluted in 0.9% physiologic serum to a
volume of 4ml. Aerosol flow was maintained at 7 l/
min and was adjusted by oxygen bursts. Radio-
aerosol inhalation was carried out with subjects
using a silicone facemask in a seated position. All
volunteers were previously trained for mask adap-
tation and deep breathing. At the 3, 6 and 9min of
inhalation, cardiorespiratory monitoring was ob-
tained by measuring inspiratory flow, Vt and minute
ventilation, using an inspiratory flow sensor
(TRACE-5; Intermed; Sa˜o Paulo, Brazil), and HR
and SpO2, using pulse oximetry.
In the SB nebulization phase, inspiration and
expiration were realized through spontaneous
unidirectional valves connected to a system of
‘‘T-tubes’’. This system was interconnected to the
radioaerosol inhalation generated by the jet nebu-
lizer and a flow sensor attached to the silicone
facemask which was attached through straps on the
volunteers face. Exhalation was realized through
expiration valves directly placed in the ‘‘Y’’ system
using an appropiate collector.
During the nebulization associated with bi-level
NV, the same ‘‘T-Tube’’ system adapted for inhala-
tion of the radioaerosol and the inspiratory flow
sensor located in the nebulization during SB were
utilized. This was connected to the ventilator
(BiPAP Synchrony Respironics Inc.; Murrysville,
USA) used on spontaneous mode, with fixed levels
of IPAP (12 cm H2O) and EPAP (5 cm H2O). During
this phase, exhalation was done via expiratory
valves of the ventilator.
Immediately after the radioaerosol radioactive
inhalation, the volunteers remained in time during
300 s in the scintigraphy camera (Forte Adac
Laboratories). The counts recorded were used to
produce static images of the pulmonary field with a
matrix of 256 256 16 in the posterior position,
which is considered the major part of lung volume.
Fig. 1 shows the analysis of pulmonary deposition
of radioaerosol. The lung was divided into central,
intermediate and peripheral regions and into upper,
middle and lower thirds, as the regions of interest
(ROIs). A comparison between pulmonary deposi-
tion in each lung was taken considering the numberof counts captured by the scintigraphy camera in
each ROI. This was used to compare the SB
nebulization phase with the nebulization asso-
ciated with bi-level NV. The ROI levels were
recorded on computer (Pegasys ADAC) after the
first phase and recaptured to be used in the analysis
in the second phase to assure that the areas studied
were the same. This was considered as the number
of pixels for each region of interest in SB and bi-
level NV phases.
Statistical analysis
Analysis of variance for repeated measures was
used to analyze pulmonary deposition of radio-
ARTICLE IN PRESS
E.E.T. Franc-a et al.724aerosol. Comparison between pairs of measures
was performed with Bonferroni method, used to
analyze pulmonary deposition of radioaerosol in the
different pulmonary regions, or with Student’s
t-test for paired samples, used to compare the
parameters obtained from cardiorespiratory mon-
itoring during inhalation in SB and associated to
bi-level NV. Simple regression Person’s analysis
was used to obtain linear correlation between
inspiratory flow and Vt and pulmonary deposition
of radioaerosol. Level of significance was 5%
(Po0:05) for all tests.Results
All subjects were able to perform measurements
without any kind of problem. Table 1 shows the
mean7SD of the initial evaluation obtained for the
group of subjects. Table 2 shows the mean7SD of
cardiorespiratory monitoring during the radioaer-
osol nebulization in SB and associated with NV bi-
level.
The image was obtained at the end of the
inhalation. Analysis of radioaerosol deposition in
the lungs showed that in SB nebulization the mean
count in each lung was 200,510711,012 and countsTable 1 Data of age, body mass index (BMI), respiratory
flow (PEF), maximal inspiratory pressure (MIP), tidal volum
volume on the 1 s (FEV1), for the group of subjects.
Initial
evaluation
Aged
(years)
BMI
(kg/m2)
RR
(ipm)
SpO2
(%)
Mean 23.30 21.3 14.4 97.6
SD 1.49 2.1 1.9 0.6
Data are presented as mean7standard deviation (SD).
Table 2 Data of cardiorespiratory monitoring: respirator
tidal volume (Vt), minute ventilation (MV), inspiratory
spontaneous breathing (SB) and associated with bi-level n
Cardiorespiratory monitoring Nebulization
Spontaneous breathi
(mean7SD)
RR (ipm) 11.572.8
HR (bpm) 71.8711.3
SpO2 (%) 98.870.5
Vt (ml) 740.07272.0
MV (l) 8074.072685.0
IF (l/min) 25.072.8from bi-level NV were 106,09372811. We observed
that pulmonary deposition of radioaerosol when
associated to bi-level NV was lower when compared
to SB (Po0:001). There was no significant differ-
ence in deposition of radioaerosol between the
right and left lungs. In SB nebulization the counts
obtained were 208,297763,202 for the right and
192,723757,796 for the left lung and in NV the
counts were 108,080747,168 for the right and
104,106749,570 for the left lung.
Fig. 2 shows radioaerosol deposition in upper,
middle and lower thirds of the lung. In all tests for
comparative analysis the radioaerosol deposition in
upper, middle and lower thirds of the lung was
lower when nebulization was carried out associated
to bi-level NV than when SB nebulization was
performed (Po0:001). There was more deposition
in middle and lower thirds than in the upper third in
both phases (Po0:05) and there was no significant
difference between middle and lower thirds in any
of the phases.
Fig. 3 shows radioaerosol deposition in central,
intermediate and peripheral regions of the lungs.
Since there was no significant difference between
left and right lungs, the radioaerosol deposition
was also compared in central, intermediate and
peripheral regions of the lungs. Radioaerosolrate (RR), oxygen saturation (SpO2), peak expiratory
e (Vt), forced vital capacity (FVC), forced expiratory
PEF
(l/s)
MIP
(cm H2O)
Vt
(ml)
FVC
(ml)
FEV1
(ml)
477.9 87.9 631.2 3581 3057
136.7 25.2 239.6 894 613
y rate (RR), oxygen saturation (SpO2), heart rate (HR),
flow (IF) during the nebulization of radioaerosol in
oninvasive ventilation (NV).
ng Associated the bi-level NV
(mean7SD)
P-values
13.473.2 ¼ 0.019
82.3714.7 ¼ 0.005
99.970.7 ¼ 0.003
1726.07624.0 o0.001
22096.078349.0 ¼ 0.001
42.0719.6 ¼ 0.005
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Figure 2 Deposition of radioaerosol in the upper, middle
and lower pulmonary regions: after nebulization in
spontaneous breathing (SB) and associated with bi-level
noninvasive ventilation (NV) (*Po0:05).
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Figure 3 Deposition of radioaerosol in pulmonary re-
gions: central, intermediate and peripheral, after neb-
ulization in spontaneous breathing (SB) and associated
with bi-level noninvasive ventilation (NV) (*Po0:05).
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Figure 4 Correlation between tidal volume and pulmon-
ary deposition of radioaerosol after nebulization in
spontaneous breathing (SB). There was an increase in Vt
and in deposition of radioaerosol during SB nebulization
(r ¼ 0:565, Po0:05).
Nebulization and noninvasive ventilation 725pulmonary deposition was lower when nebulization
associated to bi-level NV was compared to SB
nebulization in the regions analyzed (Po0:001).Although there was more radioaerosol deposition in
intermediate and peripheral than in central region
with SB and bi-level NV nebulization, there were no
significant differences in any of the phases.
Fig. 4 shows correlation between Vt and pulmon-
ary deposition of radioaerosol. There was an
increase in Vt and in deposition of radioaerosol
during SB nebulization (r ¼ 0:565, Po0:05). During
bi-level NV nebulization there was no correlation
between Vt and pulmonary deposition of radio-
aerosol in (r ¼ 0:082, P40:05). An increase in Vt did
not cause any increase in pulmonary deposition of
radioaerosol.
With respect to inspiratory flow and pulmonary
deposition of radioaerosol, there was a significant
but very low correlation in the SB nebulization
(r ¼ 0:141, Po0:05) and there was no correlation
between inspiratory flow and deposition of radio-
aerosol in bi-level NV nebulization (r ¼ 0:048,
P40:05).Discussion
In cases of asthma and bronchitis, one of the
concerns about using nebulization is to guarantee
the deposition of drugs in the area where its action
is most required. The major failure in inhalatory
treatment of asthma is the inadequate deposition
of drugs.10,16,17 Parkes and Bersten,18 studied the
dynamics of aerosol in vitro and the bronchodilata-
tion efficiency in vivo during continuous positive
airway pressure (CPAP) with facemasks in 10
asthmatic patients. Although they reported an
increase in aerosol deposition in proximal airways
because of the high gas flow in inhaling through a
CPAP, there was no effect on bronchodilatator
deposition. Fauroux et al.,19 using ventilation lung
scintigraphy studied the optimized aerosol deposi-
tion associated to pressure support ventilation
(PSV) and positive end expiratory pressure (PEEP),
with PSV levels of 8–10 cm H2O, in 18 children with
cystic fibrosis. They found an increase of 30% of
deposition in the lungs with the use of PSV without
any collection of particles in proximal airway.
Results from our study showed lower lung
deposition of radioaerosol in both lungs when
nebulization associated to bi-level NV was com-
pared to SB nebulization. These findings corrobo-
rate to those of Dollovich et al.,13 who attributed
an inspiratory flow of 40 l/min at the beginning of
inspiration and during respiration by intermittent
positive pressure to the drop of deposition in
the lung. The high flow of gas has a greater
tendency to deposit particles by impaction.20–22
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by intermittent positive pressure provide deposi-
tion of particles in the orpharynx, trachea and large
airways due to inertia impact.13
The other studies that we did using PEEP were
performed without any association with positive
pressure ventilation. The first of them23 was made
using an ultrasonic nebulizer and the second24 using
a device for expiratory positive pressure, but
without a flow generation associated, as seen in
noninvasive ventilation used in the present study.
For that matter, it is very hard to make any kind of
comparison between them.
Any comparison of the results obtained in this
study with those of Parkes and Bersten,18 and
Fauroux et al.,19 considering the efficiency of
nebulization associated with NV is not possible
because these studies were performed with distinct
groups of subjects. It is known that in normal lung
aerosol distribution in the lower airway basically
depends on gravity. However, in an asthmatic lung,
it depends on the difference of inspiratory flow
through the airway, which depends on the different
degrees of obstruction. This fact creates a hetero-
geneous deposition privileging the areas less
compromised by the disease. In general, in patients
with intense bronchiole constriction, the deposi-
tion predominates in the central airways during SB
nebulization25 and when associated to NV the
airway is kept open and consequently a better
peripheral aerosol deposition occurs.12,19
A small number of papers has been published
about the treatment of patients suffering from
bronchospasm related to asthmatic or other pa-
tients, associating NV and bronchodilators. Looking
for clinical responses, Pollack et al.12 studying
wheezing patients, showed a significantly greater
increase in percentage of peak expiratory flow rate
after NV delivered by a two-level positive pressure
ventilator compared to a simple nebulizer. How-
ever, in another study, Fauroux et al.19 observed a
greater deposition of aerosol in cystic fibrosis
children using PSV than in a control session.
Recently, Soroksky et al.26 studying 30 patients
with a severe asthma attack randomly, assigned in
the two groups treating one with noninvasive
ventilation only and the other with nebulizer. An
improved lung function was observed, as well as a
faster alleviation of the attack and a significant
reduction of the need for hospitalization. It is
possible that the differences observed between
these results and the one observed in the present
study are related to physiology. Indeed, in patients
with respiratory failure associated to a reduction in
airway diameter and consequently reduced flow, it
is possible that an increase in flow, verified whennoninvasive ventilation is used, might help these
patients. Despite the fact that these results were
observed in normal subjects we can postulate that
in clinical settings, with wheezing patients or
patients having a chronic obstructive respiratory
disease, it might be interesting to make a trial of
noninvasive ventilation.
When the lungs were partially analyzed consider-
ing upper, middle and lower thirds, deposition of
radioaerosol was greater in the middle and lower
thirds than in the upper third in both lungs with SB
nebulization and associated to bi-level NV. This
difference is attributed to the vertical pressure
gradient, which is present between base and apex
of the lung. Which means that upper and lower
parts of the lung function in different positions on
the pressure/volume curve. Consequently the
alveoli of the apex become more extended and
less yielding and therefore showing little volume
variation during inspiration.24 On the other hand,
the alveoli of the base show less expansion and
more yielding and thus have greater variation of
volume during inspiration. This fact could justify
the presence of greater deposition of radioaerosol
in the middle and lower third of both lungs since
the base has a greater variation of volume and
consequently greater renovation of inspired air
containing the radioaerosol.27–29
Analyzing the central region of the lung, more
deposition of radioaerosol was found in intermedi-
ate and peripheral areas during SB nebulization and
nebulization associated with bi-level NV. The
gradient of intrapleural pressure was relatively
uniform in the horizontal plane in which there was
no change in the horizontal gradient per unit
alveolar volume in the erect position. This reduc-
tion of radioaerosol deposition in the central region
of the lung could be attributed to some methodo-
logical problem in the scintigraphy images or to
possible radiation by the increase of the thoracic
walls resulting in a greater distance between
central region of the lung and the scintigraphy
camera as compared to other regions of the
horizontal gradient.23,30
In this study, the correlation between Vt and
inspiratory flow with radioaerosol deposition in the
lung showed that when the Vt increases together
with an increase in inspiratory flow, up to approxi-
mately 30 l/min, there is an increase in radio-
aerosol deposition in the lung. Increase in Vt
associated to low inspiratory flow resulted in a
better deposition of radioaerosol in the lung during
SB nebulization. However, during nebulization
associated to bi-level NV there was no correlation
between Vt and inspiratory flow. Increase of Vt
associated to increase of inspiration flow did not
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deposition in the lung. This lack of correlation
between the Vt and the inspiratory flow is probably
due to higher inspiratory flow rate (40 l/min) used
in bi-level NV and thus producing a greater
deposition of particles measured by collection in
the upper airways.
In summary, the results of this study suggest that
in young volunteers from both sexes and with
normal spirometry, there was a greater deposition
of radioaerosol after SB in both lungs when
compared to bi-level NV nebulization. This is
probably due to a greater inspiratory flow rate
(40 l/min) during the application of NV. The results
also suggest that in SB nebulization any increase in
Vt also caused an increase in deposition in the lung
since during SB nebulization the inspiratory flow
was lower than 30 l/min but in bi-level NV
nebulization the flow rate was greater. In SB and
NV nebulization, radioaerosol deposition was great-
er in the middle and lower regions in both lungs,
due to the regional differences of ventilation, and
in intermediate and peripheral regions, due to
lower radiation attenuation compared to the
central region.
In conclusion, during nebulization with noninva-
sive ventilation in healthy volunteers, there was an
increase in Vt associated to a higher inspiratory flow
rate, without resulting in a significant increase in
pulmonary radioaerosol deposition. Further studies
analyzing patients will be needed to clarify the
effects of nebulization associated to noninvasive
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